Your browser doesn't support javascript.
loading
AP-1 transcription factors in cytotoxic lymphocyte development and antitumor immunity.
Schnoegl, Diana; Hiesinger, Angela; Huntington, Nicholas D; Gotthardt, Dagmar.
Affiliation
  • Schnoegl D; Institute for Rheumatology and Immunology, Medical University of Graz, Austria; Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.
  • Hiesinger A; Institute of Pharmacology and Toxicology, University of Veterinary Medicine, Vienna, Austria.
  • Huntington ND; Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.
  • Gotthardt D; Institute of Pharmacology and Toxicology, University of Veterinary Medicine, Vienna, Austria. Electronic address: dagmar.gotthardt@vetmeduni.ac.at.
Curr Opin Immunol ; 85: 102397, 2023 Dec.
Article de En | MEDLINE | ID: mdl-37931499
ABSTRACT
The proper functioning of cytotoxic lymphocytes, such as natural killer and CD8+ T cells, is essential for effective cancer-immunity and immunotherapy responses. The differentiation of these cells is controlled by several transcription factors (TFs), including members of the activator protein (AP)-1 family. The activity of AP-1 family members is regulated by various immune signaling pathways, which can be triggered by activating or inhibitory receptors as well as cytokines. The target genes controlled by AP-1 TFs are central to generate immunity to pathogens or malignancies. Here, we provide an overview of the current understanding of how AP-1 TFs regulate cytotoxic lymphocytes.
Sujet(s)

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs / Antinéoplasiques Limites: Humans Langue: En Journal: Curr Opin Immunol Sujet du journal: ALERGIA E IMUNOLOGIA Année: 2023 Type de document: Article Pays d'affiliation: Australie

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs / Antinéoplasiques Limites: Humans Langue: En Journal: Curr Opin Immunol Sujet du journal: ALERGIA E IMUNOLOGIA Année: 2023 Type de document: Article Pays d'affiliation: Australie